PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Sharewise Presentation 22/7/24, page-2

  1. 4,350 Posts.
    lightbulb Created with Sketch. 6891
    Edit Q7.

    We don't have enough cash on hand for the Phase 3 currently., 4 C will show we have $20 mil. We have funding gap, we hope to fill the gap in a number of ways ---> We hope a commercial deal will go a large way to fund this gap. We have said we would prefer non dilutive cash raise on market preference to fund via commercial deal
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.